Full history for every metric is available with a Kvantra account
LexaGene Holdings Inc. (LXXGF)
Key financial summary
Financials in USD| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Total revenue | $m | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating profit | $m | -11 | -8 | |||||
| Net profit | $m | -4 | -4 | -8 | -8 | -10 | -11 | -8 |
| EPS reported | $ | -0.09 | -0.07 | |||||
| Operating cashflow per share | $ | -0.08 | -0.08 | |||||
| Capex per share | $ | 0.00 | 0.00 | |||||
| FCF per share | $ | -0.08 | -0.08 | |||||
| Free cash flow | $m | -10 | -7 | |||||
| Net debt | $m | -3 | 0 | |||||
| Book value equity | $m | 6 | - | |||||
| Book value per share | $ | 0.05 | - | |||||
| Number of shares | m | 119.98 | 139.01 | |||||
| DPS (TTM paid) | $ | 0.00 | 0.00 |
Financial summary
Financials in USD| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Value | ||||||||
| P/E TTM | x | - | - | |||||
| P/B LTM | x | 4.33 | 1.52 | |||||
| P/S LTM | x | 366.39 | 107.42 | |||||
| P/FCF LTM | x | -2.86 | -1.64 | |||||
| EV/EBITDA LTM | x | -2.40 | 0.00 | |||||
| EV/Sales LTM | x | 320.24 | 111.03 | |||||
| Earnings Yield LTM | % | -38.49% | -109.82% | |||||
| FCF Yield | % | -35.02% | -60.92% | |||||
| Quality | ||||||||
| ROE | % | -166.46% | -123.04% | |||||
| ROIC | % | -139.24% | -139.24% | |||||
| Operating margin | % | -14124.9% | -14124.9% | |||||
| Gross margin | % | -621.40% | -621.40% | |||||
| FCF/Sales | % | -12831.9% | -12831.9% | |||||
| Growth and momentum | ||||||||
| EPS Growth YoY | % | - | - | |||||
| Sales Growth YoY | % | +29.57% | -28.24% | |||||
| Net Income Growth YoY | % | - | - | |||||
| FCF Growth | % | - | - | |||||
| Operating Profit Growth | % | - | - | |||||
| Dividend and capital structure | ||||||||
| Dividend Yield | % | 0.00% | 0.00% | |||||
| Dividend Growth | % | 0.00% | 0.00% | |||||
| Payout Ratio | % | 0.00% | 0.00% | |||||
| FCF/Debt | x | -7.75 | -3.93 | |||||
| Net Debt/EBITDA | x | 0.35 | 0.35 | |||||
| EBIT/Net interest | x | -150.10 | -150.10 | |||||
| Net debt/market cap | % | -12.60% | 3.36% | |||||
| Net debt/Equity | x | -0.54 | - | |||||
| Gross debt/equity | x | 0.20 | - | |||||
Company overview
LexaGene Holdings Inc. is a biotechnology firm dedicated to the innovation, development, and market release of systems designed for identifying pathogens. Its core offering is MiQLab, an automated pathogen detection platform poised to revolutionize how pathogens are detected in diverse fields, including veterinary and human clinical diagnostics, food and water safety analysis, and other life science applications. This cutting-edge system can be deployed directly where samples are collected, providing exceptional user-friendliness, precise sensitivity, and a broad scope for pathogen identification. The company was established in 2007 and operates from its headquarters in Beverly, Massachusetts.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
LexaGene Holdings Inc. (LXXGF)
LexaGene Holdings Inc. is a biotechnology firm dedicated to the innovation, development, and market release of systems designed for identifying pathogens. Its core offering is MiQLab, an automated pathogen detection platform poised to revolutionize how pathogens are detected in diverse fields, including veterinary and human clinical diagnostics, food and water safety analysis, and other life science applications. This cutting-edge system can be deployed directly where samples are collected, providing exceptional user-friendliness, precise sensitivity, and a broad scope for pathogen identification. The company was established in 2007 and operates from its headquarters in Beverly, Massachusetts.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free